Lites for Drug Discovery

TERMS & CONDITIONS: For a limited time, receive a twenty five percent (25%) discount off the list price of select LITES research reagents using code LITES25. This offer is valid for customers in the United States, Canada, and Australia purchasing via (1) Revvity.com, (2) requisitions on the Revvity punchout (enter code in the shopping cart), and/or (3) automated e-procurement integration (cXML or EDI; reference LITES25 in the order comments). European customers in France, Germany, Spain, Italy, UK, Ireland, Sweden, Norway, Finland, Denmark, Belgium, The Netherlands, Luxembourg, Austria, and Switzerland can participate by purchasing through Revvity.com only. The aforementioned methods of purchase are the only ways for the promotion to apply, as the promotion does not apply to any orders sent by email to Revvity Customer Care. Offer excludes instruments and major accessories and is only valid for direct B2B transactions (distributors are excluded). The discount applies only to eligible items, not the entire order (unless the entire order consists of eligible items). This promotion cannot be combined with other discounts or offers, including without limitation, other price discounts, volume purchase agreements, university programs, standing order discounts or other contract pricing, and cannot be applied to existing, pending, or past orders. Customers are responsible for all applicable charges, taxes, and shipping. Offer void where prohibited, licensed, or restricted by federal, state, provincial, or local laws or regulation or agency/institutional policy. Offer is expressly not valid in any country, state, province, or locality that requires prior registration of such offer. All information submitted to Revvity will be treated in accordance with Revvity's privacy policy, available at Website privacy notice. Orders must be submitted by December 31, 2024, at 11:59 PM EST. Revvity may discontinue, suspend, or amend this discount at any time without notice for U.S., Canada, and Australia customers. Revvity has the sole discretion to determine eligibility and may request proof of eligibility​.